Cargando…

Towards next generation therapies for cystic fibrosis: Folding, function and pharmacology of CFTR()

The treatment of cystic fibrosis (CF) has been transformed by orally-bioavailable small molecule modulators of the cystic fibrosis transmembrane conductance regulator (CFTR), which restore function to CF mutants. However, CFTR modulators are not available to all people with CF and better modulators...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bose, Samuel J., Krainer, Georg, Ng, Demi R.S., Schenkel, Mathias, Shishido, Hideki, Yoon, Jae Seok, Haggie, Peter M., Schlierf, Michael, Sheppard, David N., Skach, William R.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7052731/ https://www.ncbi.nlm.nih.gov/pubmed/31902693 http://dx.doi.org/10.1016/j.jcf.2019.12.009

Ejemplares similares

CFTR trafficking mutations disrupt cotranslational protein folding by targeting biosynthetic intermediates
por: Shishido, Hideki, et al.
Publicado: (2020)

A minimal helical-hairpin motif provides molecular-level insights into misfolding and pharmacological rescue of CFTR
por: Krainer, Georg, et al.
Publicado: (2018)

Mechanisms of CFTR Folding at the Endoplasmic Reticulum
por: Kim, Soo Jung, et al.
Publicado: (2012)

Role of Hsc70 binding cycle in CFTR folding and endoplasmic reticulum–associated degradation
por: Matsumura, Yoshihiro, et al.
Publicado: (2011)

Heat treatment of thioredoxin fusions increases the purity of α‐helical transmembrane protein constructs
por: Schenkel, Mathias, et al.
Publicado: (2021)

An automated single-molecule FRET platform for high-content, multiwell plate screening of biomolecular conformations and dynamics
por: Hartmann, Andreas, et al.
Publicado: (2023)

Folding–function relationship of the most common cystic fibrosis–causing CFTR conductance mutants
por: van Willigen, Marcel, et al.
Publicado: (2019)

From CFTR biology toward combinatorial pharmacotherapy: expanded classification of cystic fibrosis mutations
por: Veit, Gudio, et al.
Publicado: (2016)

The expanding role of the ER translocon in membrane protein folding
por: Skach, William R.
Publicado: (2007)

Different Fluorophore Labeling Strategies and Designs Affect Millisecond Kinetics of DNA Hairpins
por: Hartmann, Andreas, et al.
Publicado: (2014)

A small molecule high throughput screening platform to profile conformational properties of nascent, ribosome-bound proteins
por: Shishido, Hideki, et al.
Publicado: (2022)

Nanomolar-potency ‘co-potentiator’ therapy for cystic fibrosis caused by a defined subset of minimal function CFTR mutants
por: Phuan, Puay-Wah, et al.
Publicado: (2019)

CFTR Channel Pharmacology: Novel Pore Blockers Identified by High-throughput Screening
por: Sheppard, David N.
Publicado: (2004)

Differential thermostability and response to cystic fibrosis transmembrane conductance regulator potentiators of human and mouse F508del-CFTR
por: Bose, Samuel J., et al.
Publicado: (2019)

Pharmacological Responses of the G542X-CFTR to CFTR Modulators
por: Fang, Xinxiu, et al.
Publicado: (2022)

Cystic Fibrosis, CFTR, and Colorectal Cancer
por: Scott, Patricia, et al.
Publicado: (2020)

A small molecule CFTR potentiator restores ATP‐dependent channel gating to the cystic fibrosis mutant G551D‐CFTR
por: Liu, Jia, et al.
Publicado: (2022)

Conformational Dynamics Govern the Free-Energy Landscape of a Membrane-Interacting Protein
por: Frotscher, Erik, et al.
Publicado: (2018)

Restoration of CFTR function in patients with cystic fibrosis carrying the F508del-CFTR mutation
por: Stefano, Daniela De, et al.
Publicado: (2014)

CFTR and Ca(2+) Signaling in Cystic Fibrosis
por: Antigny, Fabrice, et al.
Publicado: (2011)

Strategies to circumvent the CFTR defect in cystic fibrosis
por: Becq, Frédéric, et al.
Publicado: (2013)

Not All Is CFTR – Neutrophils and Cholesterol in Cystic Fibrosis
por: Castellani, Stefano, et al.
Publicado: (2017)

Cystic Fibrosis and Oxidative Stress: The Role of CFTR
por: Moliteo, Evelina, et al.
Publicado: (2022)

CFTR modulators: transformative therapies for cystic fibrosis
por: Dwight, Mary, et al.
Publicado: (2021)

Pharmacological Correctors of Mutant CFTR Mistrafficking
por: Pedemonte, Nicoletta, et al.
Publicado: (2012)

Folding correctors can restore CFTR posttranslational folding landscape by allosteric domain–domain coupling
por: Soya, Naoto, et al.
Publicado: (2023)

Nasal Potential Difference in Cystic Fibrosis considering Severe CFTR Mutations
por: Ng, Ronny Tah Yen, et al.
Publicado: (2015)

Inflammation and CFTR: might neutrophils be the key in cystic fibrosis?
por: Witko-Sarsat, V, et al.
Publicado: (1999)

Fixing cystic fibrosis by correcting CFTR domain assembly
por: Okiyoneda, Tsukasa, et al.
Publicado: (2012)

Targeted therapies to improve CFTR function in cystic fibrosis
por: Brodlie, Malcolm, et al.
Publicado: (2015)

Lived experiences of individuals with cystic fibrosis on CFTR-modulators
por: Page, Annelise, et al.
Publicado: (2022)

The Effect of CFTR Modulators on Airway Infection in Cystic Fibrosis
por: Harvey, Caitlyn, et al.
Publicado: (2022)

Nutritional impact of CFTR modulators in children with cystic fibrosis
por: Gaschignard, Margaux, et al.
Publicado: (2023)

Cross‐talk between CFTR and sphingolipids in cystic fibrosis
por: Dobi, Dorina, et al.
Publicado: (2023)

CFTR: the nucleotide binding folds regulate the accessibility and stability of the activated state
Publicado: (1996)

Chaperones Skp and SurA dynamically expand unfolded OmpX and synergistically disassemble oligomeric aggregates
por: Chamachi, Neharika, et al.
Publicado: (2022)

SDS-induced multi-stage unfolding of a small globular protein through different denatured states revealed by single-molecule fluorescence
por: Krainer, Georg, et al.
Publicado: (2020)

Cotranslational Folding Inhibits Translocation from Within the Ribosome–Sec61 Translocon Complex
por: Conti, Brian J., et al.
Publicado: (2014)

Pro con debates in clinical medicine infection prevention and control in cystic fibrosis: One size fits all? The argument in favour
por: Haggie, S., et al.
Publicado: (2020)

Molecular Chaperones as Targets to Circumvent the CFTR Defect in Cystic Fibrosis
por: Chanoux, Rebecca A., et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_263a14ltvfk83huakcik7kkrg3